Skip to main content
. 2019 Mar 1;5:7. doi: 10.1038/s41540-019-0087-2

Table 1.

TCGA samples used in this study

Cancer type Abbreviation Tumor samples Normal samples Patients alive Deceased patients
Breast invasive carcinoma BRCA 1057 113 900 146
Kidney renal clear cell carcinoma KIRC 526 72 345 173
Liver hepatocellular carcinoma LIHC 294 48 184 112
Prostate adenocarcinoma PRAD 379 52 367 7
Total 2256 285 1796a 438a

aThe sum of these columns does not equal the total number of tumor samples plus normal samples because survival information was missing for some patients